(Q47435359)

English

Improved DNA flow cytometric, DNA ploidy, and S‐phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

Improved DNA flow cytometric, DNA ploidy, and S‐phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines (English)

reason for preferred rank

most precise value

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566933

22 March 2024

reproducibility

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

Pär-Ola Bendahl

2

object named as

Pär-Ola Bendahl

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

4

object named as

Olle Stål

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

author name string

Bo Baldetorp

1

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

Mårten Fernö

3

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14566933

22 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cyto.a.10083

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566933

22 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcyto.a.10083

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.a.10083

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

Cytometry Part A

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

56

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

1

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

1-7

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

S-phase fraction and breast cancer--a decade of experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

S-phase fraction and nuclear size in long term prognosis of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

S-phase fraction is a prognostic factor in stage I breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories' results for 67 sample homogenates

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Quality control study by the French Cytometry Association on flow cytometric DNA content and S-phase fraction (S%). The Association Française de Cytométrie

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Preparation of tissues for DNA flow cytometric analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Picogram per cell determination of DNA by flow cytofluorometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

S-phase fraction assessed by a variant of the rectangular model adapted to the flow-cytometric DNA histogram profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

21 January 2018

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10083

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

19

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival

38

1 reference

10.1002/CYTO.A.10083

https://api.crossref.org/works/10.1002/CYTO.A.10083

22 March 2024

Identifiers

10.1002/CYTO.A.10083

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14566933

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47435359&oldid=2108786770"